← Leaderboards
Lawrence D Recht
Univ Of Massachusetts Med Sch Worcester
$4,694,963
Attributed
$6,442,587
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $638.6K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,627,148 · 15
By mechanism
R01$5,011,761 · 3
P01$2,184,561 · 1
R21$813,921 · 2
P30$606,291 · 2
M01$10,614 · 7
Top collaborators
- Daniel M Spielman8 shared
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsMalignant NeoplasmsSafetyTissuesResearch PersonnelBaseGrantProtocols DocumentationResearch StudyClinical ResearchSignal TransductionLabelResponseMonitorIn VivoResourcesPharmaceutical PreparationsAuthorityFundingMedicalDoseRecommendationEnsureReview Committee
Grant awards (37)
Protocol Review and Monitoring System$169,871
P30 · FY2025 · CA · contact PI
Protocol Review and Monitoring System$42,202
P30 · FY2024 · CA · contact PI
Protocol Review and Monitoring System$42,202
P30 · FY2023 · CA · contact PI
Imaging Biomarkers for Glioma Treatment Response$216,751
R01 · FY2022 · CA
Protocol Review and Monitoring System$42,202
P30 · FY2022 · CA · contact PI
Imaging Biomarkers for Glioma Treatment Response$221,174
R01 · FY2021 · CA
Imaging Biomarkers for Glioma Treatment Response$275,857
R01 · FY2020 · CA
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-014)$63,385
P30 · FY2020 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-014)$63,192
P30 · FY2019 · CA · contact PI
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate$556,142
R01 · FY2018 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-014)$63,385
P30 · FY2018 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-014)$11,296
P30 · FY2018 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-014)$7,796
P30 · FY2018 · CA · contact PI
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate$548,510
R01 · FY2017 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-014)$47,647
P30 · FY2017 · CA · contact PI
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate$553,640
R01 · FY2016 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-014)$53,113
P30 · FY2016 · CA · contact PI
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate$548,148
R01 · FY2015 · CA · contact PI
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate$575,027
R01 · FY2014 · CA · contact PI
Quantifying Cortical Neuron Production After Transplantation$176,713
R21 · FY2008 · NS · contact PI
CDOn: A Novel Marker of Neuronal Stem Cells$174,125
R21 · FY2008 · NS · contact PI
CDOn: A Novel Marker of Neuronal Stem Cells$40,000
R21 · FY2008 · NS · contact PI
CLINICAL TRIAL: PERITUMORAL BRAIN EDEMA IN PATIENTS WITH PRIMARY MALIGNANT GLIOM$1,479
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: HCRF FOR PATIENTS WITH MALIGNANT BRAIN TUMOR WHO REQUIRE HIGH-DO$796
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: DEXAMETHASONE-SPARING STUDY COMPARING (HERF) TO PLACEBO$569
M01 · FY2008 · RR · contact PI
Quantifying Cortical Neuron Production After Transplantation$215,175
R21 · FY2007 · NS · contact PI
SPO 33555: CDOn: A novel marker of neural stem cells$207,908
R21 · FY2007 · NS · contact PI
DEXAMETHASONE-SPARING STUDY COMPARING HERF TO PLACEBO$2,926
M01 · FY2007 · RR · contact PI
HCRF FOR PATIENTS WITH MALIGNANT BRAIN TUMOR WHO REQUIRE HIGH-DOSE DEXAMETHASONE$1,755
M01 · FY2007 · RR · contact PI
PERITUMORAL BRAIN EDEMA IN PATIENTS WITH PRIMARY MALIGNANT GLIOMA; (HCRF) TO DEX$1,755
M01 · FY2007 · RR · contact PI
PERITUMORAL BRAIN EDEMA IN PATIENTS WITH MALIGNANT BRAIN TUMOR$1,334
M01 · FY2006 · RR · contact PI
Stem Cell Plasticity after Blastocyst Implantation$382,841
R01 · FY2004 · NS
Stem Cell Plasticity after Blastocyst Implantation$379,215
R01 · FY2003 · NS
NEURAL STEM CELLS AND NEURO-ONCOLOGY$1,105,395
P01 · FY2002 · CA
Stem Cell Plasticity after Blastocyst Implantation$379,215
R01 · FY2002 · NS
NEURAL STEM CELLS AND NEURO-ONCOLOGY$1,079,166
P01 · FY2001 · CA
Stem Cell Plasticity after Blastocyst Implantation$375,241
R01 · FY2001 · NS